Skip to main content

Table 3 Relative risk of comorbidities, laboratory parameters and immunological markers in the mortality of HIV/AIDS patients

From: Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon

Characteristic Death RR 95% CI p-value
Yes No
N = 17 N = 66
Digestive syndromea 8/17 (47%) 16/66 (24%) 3.05 (1.55–6.06) 0.001
Tuberculosisa 12/17 (71%) 25/66 (38%) 4.62 (1.87–11.36) 0.001
IL.8 pg/mLb 90.4 (20–189.0) 26.1 (14.0–90.1) 1.01 (1.00–1.01) 0.007
Lymphocytesb in percentage 20.5 (10.3) 27.4 (13.5) 0.95 (0.91–0.98) 0.003
LDH U/uL** (120 and 246 U/uL) 435 (332–534) 367.5 (300.2–474.2) 1.01 (1.00–1.01) 0.001
  1. Relative risk; CI: confidence interval; and the p-value was calculated using the Poisson regression; LDH: lactate dehydrogenase
  2. aAmong the categorical variables, the statistics were presented as n/N (%); where n = number of patients for whom the variable was positive. N represents total number in each group
  3. bAmong the numerical variables, statistics were presented as median (Q1–Q3) or mean (SD)
  4. **: References value of lactate dehydrogenase (120 and 246 U/uL)